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Abstract: Developmental exposure to toxicants and diet can interact with an individual’s genetics
and produce long-lasting metabolic adaptations. The different isoforms of the apolipoprotein E
(APOE) are an important source of variability in metabolic disorders and influence the response to the
pesticide chlorpyrifos (CPF). We aimed to study the epigenetic regulation on feeding control genes
and the influence of postnatal CPF exposure, APOE genotype, and sex, and how these modifications
impact on the metabolic response to a high-fat diet (HFD). Both male and female apoE3- and
apoE4-TR mice were exposed to CPF on postnatal days 10–15. The DNA methylation pattern of
proopiomelanocortin, neuropeptide Y, leptin receptor, and insulin-like growth factor 2 was studied in
the hypothalamus. At adulthood, the mice were given a HFD for eight weeks. The results highlight
the importance of sex in the epigenetic regulation and the implication of CPF treatment and APOE
genotype. The body weight progression exhibited sex-dimorphic differences, apoE4-TR males being
the most susceptible to the effects induced by CPF and HFD. Overall, these results underscore the
pivotal role of sex, APOE genotype, and developmental exposure to CPF on subsequent metabolic
disturbances later in life and show that sex is a key variable in epigenetic regulation.
Keywords: chlorpyrifos; APOE; epigenetics; feeding control; high-fat diet
1. Introduction
Obesity has undeniably increased its worldwide prevalence in recent decades. It is a
major risk factor for other common diseases such as type 2 diabetes, metabolic syndrome,
and some types of cancer [1]. According to the Developmental Origins of Health and
Disease (DOHaD) hypothesis, early life factors such as diet, stress, or exposure to toxi-
cants can increase vulnerability to chronic diseases later in life [2,3]. Hence, obesity can
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be modulated by the developmental alterations of metabolic programming and energy
homeostasis [4]. Interestingly, the organophosphate pesticide chlorpyrifos (CPF), whose
main mechanism of action is the inhibition of the enzyme acetylcholinesterase [5,6], can
elicit neurotoxic effects and modulate metabolic homeostasis. CPF is a worldwide used pes-
ticide for crop protection and the general population is mainly exposed to it through their
diet [7]. In previous studies in rodents, we found that animals fed a CPF-supplemented
diet during adulthood presented a phenotype resembling obesity in a genotype-dependent
manner [8,9]. More specifically, CPF-treated mice presented increased glucose and insulin
levels in plasma, higher insulin resistance, and greater ghrelin levels than their control
peers [8]. In recent in vitro investigations, we also found that CPF can enhance adipocyte
differentiation in a culture of undifferentiated murine pre-adipocytes and increase their
ability to store lipids [10].
Remarkably, the human polymorphic apolipoprotein E (APOE) gene, which encodes
for a protein involved in lipid transport, presents three main isoforms in humans: apoE2,
apoE3, and apoE4 [11]. These isoforms are an important source of variability in responses
to toxic insults and diet variations. APOE genotypes have different metabolic profiles, with
different susceptibilities to obesity and insulin resistance. For instance, mice expressing the
human form of APOE3 presented a higher body weight than their APOE4 counterparts after
a high-fat diet [12–14], which can be attributed to a more efficient use of nutrients by animals
expressing the apoE3 isoform [13]. In turn, a higher risk of developing impaired tolerance
to glucose and diabetes mellitus-like metabolic traits was observed in ε4 carriers [12,14].
The different isoforms of the APOE gene also have different responses to toxic insults,
including exposure to CPF [15,16]. The greater vulnerability of mice carrying the human
form of the APOE3 gene to developing an obese-like phenotype [8,9] is explained by the
capacity of CPF to disrupt the homeostasis of insulin and leptin signaling pathways, so the
incidence in this genotype is greater [17].
Early life exposure to CPF could predispose to the development of metabolic alter-
ations later in life [18]. Developmental exposure to CPF has shown long-term effects over a
broad spectrum of functions, including learning and memory [16,19], as well as the cerebral
expression of cholinergic elements [16,20]. Since the long-term effects of developmental ex-
posure are regularly observed, epigenetic regulation—including DNA methylation, histone
modifications and micro-RNA activity—has emerged as a plausible mechanism. In fact,
DNA methylation is the most studied epigenetic mechanism and consists of the addition
of a methyl group to a cytosine within a CpG dinucleotide in the DNA sequence [21]. The
methylation of specific zones, generally in the promoter region, can modulate transcription
and regulate gene expression [22].
While cognitive and motor deficits caused by CPF have been the object of consider-
able study, less attention has been paid to the link between this pesticide and metabolic
disturbances. Feeding behavior, body weight (BW), and energy expenditure are primar-
ily regulated by the hypothalamus, in close communication with peripheral and central
signals. The neurons in the arcuate nucleus (ARC) are important responders to these
signals [23]. In rodents, neurons in the ARC proliferate and differentiate during the
embryonic period and send axons to their targets during the postnatal weeks prior to
weaning [24,25]. These early developmental periods are especially sensitive to environ-
mental factors and program metabolic tone in adults [26]. Two different types of neurons,
mainly found in the ARC of the hypothalamus synthesize either anorexigenic or orexigenic
neuropeptides in response to leptin, ghrelin, and insulin signaling [27–29]. Leptin, a hor-
mone secreted in the adipose tissue, binds to leptin receptors (LEPR) in the hypothalamus
and triggers multiple signaling cascades. This stimulates the synthesis of anorexigenic
neuropeptides—proopiomelanocortin (POMC) and cocaine-and-amphetamine regulated
transcript (CART)—and inhibits the synthesis of orexigenic neuropeptide Y (NPY) and
agouti-related peptide (AgRP) [27,30]. Ghrelin, an orexigenic peptide hormone, can also
regulate appetite by binding to the ghrelin receptor (GHSR1α) in the hypothalamus, which
promotes food intake and adiposity [31]. Furthermore, insulin-like growth factor 2 (IGF2),
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an imprinted gene mostly known for its implication in development, can play a role in the
hypothalamic regulation of appetite by inhibiting the orexigenic action of NPY [32].
Taking the above into account, to examine long-term altered energy homeostasis
induced by CPF, in this study we investigated DNA methylation as the mechanism of
epigenetic regulation of several genes in the hypothalamic area, which is involved in
feeding control and energy balance. The study was conducted in a transgenic mouse model
for the human APOE3 and APOE4 genotype exposed to CPF during the postnatal period.
Thereafter, we introduced a high-fat diet to focus on how these factors influenced metabolic
homeostasis in an obesogenic environment.
2. Material and Methods
2.1. Animals and Care
Male and female apoE-TR mice, homozygous for the ε3 and ε4 alleles, respectively
(Taconic Europe, Lille Skensved, Denmark), were used. This apoE-TR animal model has
a C57BL/6 background, with the human allele apoE replacing the murine gene [33]. The
animals were housed under a 12 h light/dark automatic light cycle (light on 8:00–20:00) in
standard conditions (temperature of 22 ± 2 ◦C and humidity of 50 ± 10%), with 2–5 indi-
viduals of the same genotype per cage. All mice were allowed free access to fresh water
and were fed a normal chow diet (Panlab, Barcelona, Spain). The experimental timeline is
shown in Figure 1. The use of animals and the experimental protocol were approved by
the Animal Care and Use Committee of the Rovira i Virgili University (Tarragona, Spain).
The experiments were conducted in accordance with Spanish Royal Decree 53/2013 on
the protection of experimental animals, and the European Communities Council Directive
(2010/63/EU).
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Figure 1. Experimental timeline including the treatment period from postnatal days (PND) 10 to 15 and sacrifice to obtain 
biological samples at PND 45. At postnatal month (PNM) 3, the animals were subjected to the high-fat diet (HFD) until PNM 5. 
Abbreviations: CPF: chlorpyrifos. 
2.2. Chemicals and Treatment 
CPF [0,0-diethyl O-(3,5,6-trichloropyridin-2-yl) phosphorothioate], purity 99.5%, was 
obtained from Sigma-Aldrich Co. LLC (Madrid, Spain). The compound was dissolved in 
corn oil and adjusted in order to administer 1 mg/kg in 1 μL/g of body weight. We dis-
tributed the animals in two different groups: the CPF-treated group was orally treated 
with CPF on postnatal days (PND) 10–15 using a micropipette, while the control group 
was given the vehicle for the same period. The animals were periodically monitored and 
maintained under standard conditions. 
Figure 1. Experimental timeline including the treatment period from postnatal days (PND) 10 to 15 and sacrifice to obtain
biological samples at PND 45. At postnatal month (PNM) 3, the animals were subjected to the high-fat diet (HFD) until
PNM 5. Abbreviations: CPF: chlorpyrifos.
2.2. Chemicals and Treatment
CPF [0,0-diethyl O-(3,5,6-trichloropyridin-2-yl) phosphorothioate], purity 99.5%, was
obtained from Sigma-Aldrich Co. LLC (Madrid, Spain). The compound was dissolved
in corn oil and adjusted in order to administer 1 mg/kg in 1 µL/g of body weight. We
distributed the animals in two different groups: the CPF-treated group was orally treated
with CPF on postnatal days (PND) 10–15 using a micropipette, while the control group
was given the vehicle for the same period. The animals were periodically monitored and
maintained under standard conditions.
2.3. Brain Sampling
At PND 45, biological samples were collected. The animals were deeply anesthetized
with isoflurane using a SomnoSuite Low Flow Vaporizer anesthesia system (Kent Scientific,
Torrington, CT, USA) and then euthanized by decapitation. Whole brains were collected
and dissected to obtain the hypothalamus. Samples were snap frozen in liquid nitrogen
and immediately stored at −80 ◦C until analysis.
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2.4. Isolation of DNA and RNA
DNA and RNA were simultaneously extracted from the hypothalamus samples,
using an Allprep DNA/RNA Mini Kit (Qiagen Inc., Hilden, Germany). The nucleic acid
concentration and purity were measured using a Nanodrop 2000c spectrophotometer
(ThermoFisher Scientific, Waltham, MA, USA). We included the following groups: control
apoE3-TR males (n = 5), control apoE3-TR females (n = 6), CPF-treated apoE3-TR males
(n = 6), CPF-treated apoE3-TR females (n = 6), control apoE4-TR males (n = 6), control
apoE4-TR females (n = 6), CPF-treated apoE4-TR males (n = 6) and CPF-treated apoE4-TR
females (n = 6).
2.5. Methylation Analysis: Bisulfite Modification and Pyrosequencing
A total of 500 ng of genomic DNA was used for bisulfite conversion using an EZ DNA
Methylation-Gold Kit (Zymo Research, Irvine, CA, USA). Bisulfite sequencing primers
for the different genes were designed using PyroMark assay design software (Qiagen Inc.,
Hilden, Germany). Because of its influence on the transcription of the gene, the assays
prioritized the study of the promoter region. The details for the primer sequences are
summarized in Table 1. PCRs were carried out for each gene in a total volume of 25µL.
Methylation was determined by pyrosequencing on a PyroMark Q48 (Qiagen Inc., Hilden,
Germany). The results were analyzed by PyroMark Q48 Autoprep 2.4.2. Software (Qiagen
Inc., Hilden, Germany).





















Primer sequences are of our own design, except for the Igf2 DMR2, which was designed by Freitag et al. (2014) [34].
2.6. Gene Expression Analysis
The gene expression of Pomc, Npy, Lepr, and Igf2 was assessed by real-time polymerase
chain reaction (qPCR). The complementary DNA (cDNA) was synthetized from 0.5 µg of
RNA from each sample, using a Maxima First Strand cDNA Synthesis Kit for RT-qPCR
(ThermoFisher Scientific, Waltham, USA). The qPCR for each gene was performed using a
Maxima SYBR Green/ROX qPCR Master Mix (2X) kit (ThermoFisher Scientific, Waltham,
USA) and Rotor-Gene Q Real-Time PCR cycler (Qiagen Inc., Hilden, Germany). The
primers used are shown in Table 2. Rotor-Gene Q 2.0 software was used to calculate the
cycle threshold (Ct) and the relative levels of expression of the target genes were normalized
to housekeeping gene Gapdh with the 2−∆∆Ct method.
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Table 2. Sequence of primers used in the gene expression analysis.
Gene Forward Sequence Reverse Sequence Reference
LepR CGTGGTGAAGCATCGTACTG GGGCCATGAGAAGGTAAGGT [35]
Pomc AGAACGCCATCATCAAGAAC AAGAGGCTAGAGGTCATCAG [36]
Npy * TGGACTGACCCTCGCTCTAT GTGTCTCAGGGCTGGATCTC [37]
Igf2 ACACGCTTCAGTTTGTCTGTTC GGGGGTGGCACAGTATGTC [38]
Gapdh ACAACTTTGGCATTGTGGAA GATGCAGGGATGATGTTCTG [39]
Primer sequences have been evaluated by Primer BLAST. Genes with an asterisk (*) are described for another
type of rodent. These sequences were checked and matched to the mouse genome.
2.7. Dietary Intervention: High-Fat Diet
At three months of age, another set of animals subjected to the same postnatal treat-
ment, underwent a dietary intervention in order to better understand the extent of the
epigenetic regulation of body weight and food intake in an obesogenic environment. Before
the challenge, they were paired according to sex, genotype, and postnatal treatment. Body
weight and food intake were measured twice a week for one week (week 0). The animals
were then distributed in two dietary groups: the first one received a high-fat diet (HFD)
(Purified diet 230 HF, SAFE, Augy, France). It contained 5.32 kcal/g, with 13.1% proteins,
26.3% carbohydrate and 60.6% fat. The second group was fed a standard maintenance
chow diet (SAFE A04 diet, Panlab, Barcelona, Spain). This diet contained 3.34 kcal/g, with
19.3% proteins, 72.4% carbohydrates and 8.4% fat. The dietary intervention lasted for eight
weeks, and body weight (g) and food intake were assessed twice a week. The number of
animals in each group is shown in Table 3.
Table 3. Number of animals in each group in the high-fat diet (HFD) challenge.











Abbreviations: CNT, control; CPF, chlorpyrifos-treated; HFD, high-fat diet.
2.8. Statistical Analysis
Data were analyzed with the SPSS 26.0 software (IBM Corp, Chicago, IL, USA). The
results of the methylation analysis and the gene expression were studied with a three-
way analysis of variance (ANOVA), with sex, genotype, and treatment as the main factors.
Pearson correlations were used to investigate associations between methylation and mRNA
levels. The body weight was studied with an ANOVA for repeated measures. Tukey’s
post-hoc test of variance was used to analyze differences between groups. The homogeneity
of the variance was assessed by a Levene test. Statistical significance was set at p < 0.05.
Results are reported as mean values ± S.E.M.
3. Results
3.1. DNA Methylation and Gene Expression
The methylation status was analyzed for each CpG position within the target region of
the genes studied: Pomc, Npy, Lepr, and Igf2. Then, we assessed the mean methylation levels
of the region studied by calculating the arithmetic mean of the analyzed CpG positions
Int. J. Environ. Res. Public Health 2021, 18, 184 6 of 17
for each gene in order to get a better understanding of the methylation status. Eventually,
gene expression was determined and the possible relation between methylation and gene
expression was analyzed.
3.1.1. Pomc Methylation is Highly Influenced by Sex while CPF Modulates Gene
Expression Levels
A total of 12 CpG positions were analyzed for the Pomc gene, all of them being
in the promoter region. Differences in the percentage of methylation were assessed
by a three-way ANOVA (sex × genotype × treatment) for each CpG site. Sex was ob-
served to have a significant effect on methylation levels in positions −203 [F(1,39) = 6.086,
p = 0.018], −184 [F(1,39) = 10.504, p = 0.002], −170 [F(1,39) = 19.466, p < 0.001], −160
[F(1,38) = 7.544, p = 0.009],−158 [F(1,39) = 5.100, p = 0.030],−120 [F(1,39) = 5.963, p = 0.019],
−104 [F(1,39) = 4.947, p = 0.032], −94 [F(1,39) = 13.394, p = 0.001] and −84 [F(1,39) = 8.382,
p = 0.006]. Methylation levels were highest for males. The study of the mean methyla-
tion of the 12 CpG positions in the Pomc promoter showed a significant sex difference
[F(1,37) = 7.572, p = 0.009], with males presenting higher methylation levels than females
(Figure 2A). An interaction between genotype and sex [F(1,39) = 5.978, p = 0.019] and
between sex and treatment [F(1,39) = 4.931, p = 0.032] was observed in CpG position −134.
Further analysis by a one-way ANOVA (genotype) for each sex revealed that apoE4-TR
males exhibited a higher percentage of methylation than apoE3-TR males (Figure 2B).
Interestingly, apoE3-TR males were more susceptible to the effects of CPF, having higher
methylation levels than their control counterparts. This effect was not observed in females.
On the other hand, the gene expression results revealed that the treatment had a significant
effect [F(1,38) = 4.991, p = 0.031], with the CPF-treated groups presenting higher mRNA ex-
pression levels than control (Figure 2C). The Pearson correlation test showed no significant
correlations between methylation levels and the gene expression results.
3.1.2. CPF Treatment Modulates Npy Methylation Only in Males
The assay designed for Npy covered a total of seven CpG positions, all in the promoter
region. However, we could only trust three of them because of technical issues with the
remaining four positions. The study of each position found no differences between groups,
although the mean methylation of the region revealed significant differences. More specif-
ically, we observed an interaction between sex and postnatal treatment [F(1,37) = 5.489,
p = 0.025], with CPF-treated males exhibiting lower methylation than control males (Figure 3A).
The results of the gene expression analysis showed no significant differences between
groups (Figure 3B). Nevertheless, a negative correlation was found between the mean
methylation and mRNA levels in males (r = −0.466, p = 0.029), while a positive correlation
was found in females (r = 0.740, p < 0.001).
3.1.3. Lepr Presents Sexual-Dimorphic Differences only in the APOE3 Genotype
A total of 17 CpG positions were analyzed in the case of Lepr, distributed within
the promoter. Differences in the percentage of methylation were assessed by a three-way
ANOVA (sex × genotype × treatment) for each CpG site. Sex was found to have a signifi-
cant effect at positions −42 [F(1,39) = 7.888, p = 0.008] and +15 [F(1,39) = 11.080, p = 0.002],
with males showing higher methylation levels. An interaction between genotype and sex
was observed at position −61 [F(1,39) = 7.809, p = 0.008], position −42 [F(1,39) = 4.181,
p = 0.048], and position −40 [F(1,39) = 4.902, p = 0.033]. The study of the mean methyla-
tion levels of the 17 CpG positions in the Lepr promoter showed a tendency towards an
interaction between sex and genotype [F(1,39) = 3.844, p = 0.057], which suggests a higher
percentage of methylation in apoE3-TR males than in apoE3-TR females [F(1,23) = 5.698,
p = 0.028] (Figure 4A). Moreover, CpG site −40 showed a triple interaction between sex,
genotype and treatment [F(1,39) = 4.672, p = 0.037] as well as a tendency towards higher
methylation levels in CPF-treated apoE3-TR males than in their respective control group
(Figure 4B). On the other hand, gene expression results revealed a tendency towards an
interaction between genotype and treatment [F(1,38) = 3.543, p = 0.067]. Significant differ-
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ences were found between apoE3- and apoE4-TR mice only in those animals that had been
treated with CPF [F(1,18) = 4.603, p = 0.046]. The CPF-treated apoE4-TR group presented a
higher expression than mice in the CPF-treated apoE3-TR group (Figure 4C). The Pearson
correlation test showed a negative correlation between the mean methylation of the target
region and mRNA levels (r = −0.331, p = 0.026). Moreover, a negative correlation of CpG
positions −40 (r = −0.345, p= 0.020) and −61 (r = −0.329, p = 0.027) with the mRNA levels
showed the influence of these two positions on the transcription of the Lepr gene.
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3.1.4. Igf2 Methylation Levels Depend on Sex
Five CpG positions were analyzed in the Igf2 gene, all of which were in the DMR2
region. DMR2 is a well-studied intragenic regulatory region that is highly sensitive to
methylation [40]. The differences in the percentage of methylation were assessed by a
three-way ANOVA (sex × genotype × treatment) for each CpG site. Sex was noted to
have a significant effect on methylation levels at all the positions: +12383 [F(1,39) = 14.485,
p < 0.001], +12392 [F(1,39) = 17.818, p < 0.001], +12395 [F(1,39) = 26.425, p < 0.001], +12401
[F(1,39) = 14.518, p < 0.001] and +12409 [F(1,39) = 20.440, p < 0.001]. Levels were higher in
females. Likewise, the study of the mean methylation levels in the five CpG positions in the
DMR2 region of Igf2 gene showed significant sex differences [F(1,39) = 27.958, p < 0.001],
with females showing higher methylation percentages than males (Figure 5A). Interactions
between sex and treatment [F(1,39) = 4.191, p = 0.047] and between sex, genotype and
treatment [F(1,39) = 7.018, p = 0.012] were observed at CpG position +12395. Further
analysis with a one-way ANOVA (group) followed by a post-hoc analysis for each sex found
that expression was higher in the CPF-treated apoE4-TR females (Figure 5B). The results
of the Igf2 gene expression showed no significant differences between groups (Figure 5C),
while no significant correlations were found between methylation and mRNA results.
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3.2. Dietary Challenge: High-Fat Diet
Body Weight Progression is Influenced by CPF Exposure Only for the APOE4 Genotype
Body weight progression during the postnatal period (PND 4 to PND 28) was assessed
by a three-way ANOVA (sex × genotype × treatment) for repeated measures, with time
as the within-subject factor. We observed a significant effect of time [F(3,87) = 2477.340,
p < 0.001], an interaction between time and sex [F(3,87) = 10.081, p < 0.001], between time,
genotype, and treatment [F(3,87) = 3.223, p = 0.026], and between time, sex, genotype,
and treatment [F(3,87) = 3.843, p = 0.012]. For this reason, from this point on, we studied
the differences for each genotype and sex separately. A one-way ANOVA (treatment)
revealed treatment differences at PND 28 in apoE4-TR mice (males: [F(1,29) = 13.525,
p = 0.050]; females: [F(1,30) = 5.861, p = 0.022]). Animals in the CPF-treated group presented
significantly higher body weights than those in control group (Figure 6C,D).
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Body weight progression during the 8-week HFD challenge was studied by a two-way
ANOVA (treatment × diet) for repeated measures, with time as the within-subject factor.
We found a significant effect of time (p < 0.050) and a significant interaction between time
and diet (p < 0.050) in all groups. In order to further study the weekly development of BW,
a two-way ANOVA (treatment × diet) was used to assess the weekly differences between
groups. ApoE3-TR males presented a permanent effect of the diet from week 5 on, whereas
in apoE3-TR females this effect was observed from week 2 onwards (Figure 6A,B). In apoE4-TR
males a significant effect of the CPF treatment was observed during the first weeks of the
HFD (week 2 to week 4), when CPF-treated animals fed a HFD did not increase their BW
in the same way as their control pairs. However, the influence of the diet was observed
from week 4 until the end of the challenge (Figure 6C). The diet affected apoE4-TR females
between week 3 and week 8 (Figure 6D). These results showed that CPF exposure had an
impact only on apoE4-TR males.
4. Discussion
The present investigation was designed to study how APOE genotype, sex, and
postnatal exposure to the pesticide CPF regulates the methylation of genes involved
in feeding control, and how these epigenetic modifications can condition the subject’s
outcomes in an obesogenic environment with a HFD. In recent studies, we have reported
the capacity of CPF to alter insulin and leptin signaling pathways [17], and to increase body
weight in a genotype-dependent manner [8,9]. Even though the underlying mechanisms
have not been yet completely elucidated, we hypothesize that epigenetic modifications
may be involved. Previous studies have demonstrated that the genes integrating the
feeding control pathway in the hypothalamus can be highly influenced by epigenetic
regulations [23]. Furthermore, epigenetic modifications are especially relevant during
critical developmental periods and can impact long-term health [41–43]. To the best of
our knowledge, the current study has been the first one assessing how CPF epigenetically
regulates genes involved in the feeding control pathway and the subsequent life-long
metabolic implications, in a sex- and APOE-dependent manner.
Environmental factors can influence the methylation pattern of genes during critical
developmental periods. It has been reported that the appetite-regulating neuropeptides
Pomc and Npy have been epigenetically modified by dietary interventions such as postnatal
overfeeding [44], high-fat diet feeding [45–48], or dietary restrictions [49]. Moreover, gesta-
tional exposure to environmental pollutants such as the synthetic antibacterial triclosan
altered Pomc promoter methylation and gene expression in mice, linked to a postnatal
hyperphagic obesity [50]. In the same line, genome-wide DNA methylation studies in
humans have found a link between higher exposure to organophosphate pesticides and
modifications in the methylation of several genes [51,52]. Nevertheless, the specific modifi-
cations in methylation induced by CPF in the genes involved in energy homeostasis remain
unascertained.
For the study of the methylation pattern of the gene coding for the anorexigenic
neuropeptide POMC, we targeted two consecutive regions in the promoter analogous to
those investigated in previous studies on mice [49,53,54]. Significant differences between
groups were found at ten CpG positions, most of which were highly influenced by sex. In
fact, males showed a higher methylation percentage than females. This is in agreement
with the premise that the regulation of several aspects of energy homeostasis depends on
the sex [55]. Some positions can be in the binding site for specific transcription factors, so
they may have more influence on regulating gene expression. This is the case of specificity
protein 1 (Sp1), whose binding site includes CpG position −94 in the promoter of the Pomc
gene. Sp1 is critical for leptin signal transduction after leptin binds to Lepr: Sp1 binds to
Pomc and interacts with phosphorylated STAT3 to regulate Pomc promoter activity [56].
Therefore, hypermethylation at this position interferes with the Sp1 binding and decreases
Pomc gene expression [54]. Previous studies in rats have found that this position is a target
for methylation modifications in response to dietary interventions [44,46]. In the current
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investigation, we found that methylation in this specific position was higher in males than
in females. Despite the fact that sex differences have not been extensively studied, with
most of the studies focusing on one sex, a recent study including both males and females
found subtle sex differences in the Pomc methylation pattern [48].
On the other hand, the current study found higher levels of Pomc gene expression in
the CPF-treated group but no significant correlations between the mRNA and methylation
levels. Even though some studies have found a negative correlation between methylation
status and gene expression [57,58], others, like ours, have not [46,53,59]. A plausible
explanation for this discrepancy could be the involvement of other epigenetic mechanisms
or the influence of other regions in the regulation of Pomc gene expression. It is also worth
noting that Pomc is under the regulatory control of leptin [30], so we hypothesize that
changes in the leptin levels are necessary to observe significant effects on Pomc expression.
We then studied the epigenetic regulation of the gene coding for the orexigenic
neuropeptide NPY. The Npy gene promoter presented low methylation levels, up to 2.5%,
which is in accordance with the results of previous studies [44]. Despite these low levels
and the fact that only three CpG positions were analyzed, we observed that the mean
methylation levels are influenced by sex and treatment. More specifically, CPF-treated
males presented lower methylation levels than their respective controls, suggesting that
males are more sensitive than females to CPF. This sexual-dimorphic sensitivity has been
also observed with other toxics such as the pesticide tributyltin [60]. Along the same
lines, the male but not female offspring of dams exposed to ambient fine particles (PM2.5)
showed higher expression of the hypothalamic Npy gene [61]. Higher expression of Npy in
CPF-treated males would lead to an upregulation to higher food intake and BW, which is
in agreement with previous observations of CPF inducing increased BW in adult mice [8,9].
The methylation analysis of Lepr showed sexual dimorphic differences in the APOE3
genotype, with higher mean methylation levels in males. In addition, CpG position −40
also presented significant differences between males and females, being methylation levels
of apoE3-TR males higher than those of apoE4-TR males. Altogether, these observations
highlight the influence of the APOE genotype, and its interaction with sex, on the Lepr
signaling pathway in the hypothalamus. Interestingly, the apoE gene has been reported
to play a role in the regulation of food intake [62,63]. Firstly, apoE is highly expressed in
the ARC and PVN of the hypothalamus [62]. Secondly, the intraventricular injection of
apoE decreased food intake and BW in rats, whereas the injection of an apoE antiserum
increased these same parameters [62]. Thirdly, a link has been reported between apoE
levels and leptin signaling throughout the Lepr in ARC astrocytes [63]. Considering all the
evidence, it is not surprising that the APOE isoform can lead to differences in the leptin
signaling pathway.
Gene expression analysis of Lepr in the hypothalamus has found a tendency towards
an interaction between genotype and treatment, which highlights the potential influence
of CPF on leptin signaling. Previous studies with males have reported that the APOE
genotype determines the response to CPF in terms of the hepatic protein expression of
the SOCS3 and the ratio between phospho-STATS3 and total STATS3, both involved in
the leptin signaling pathway [17]. Indeed, CPF-treated apoE3-TR males presented higher
levels than apoE4-TR males [17]. Interestingly, in the present investigation the results of
gene expression negatively correlated with the data of methylation analysis, suggesting
that higher methylation inhibits gene expression and vice-versa. These findings support
the implication of epigenetic modification in the regulation of Lepr gene expression in the
hypothalamus.
In the case of the Igf2 gene the region selected to study the methylation pattern was the
DMR2. The results showed a clear effect of sex, with females presenting higher methylation
levels than males. Gene expression analysis showed no significant differences between
groups nor a correlation with methylation results. The study of Igf2 methylation levels
in several tissues also showed sex- and age-dependent differences between groups [64]
and the higher methylation of Igf2 has been associated with lower BMI [65]. Indeed, Igf2 is
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mainly known for its role in embryonic development. However, it has also been reported
that it contributes to the control of energy homeostasis. In fact, Igf2 and its receptors are
expressed in the hypothalamus, more specifically in the PVN [66]. Intracerebroventricular
infusions of Igf2 in rats showed a dose-dependent decrease in food intake and BW [67] by
decreasing the release of Npy in the hypothalamus in a similar way to insulin [32].
Overall, the results of the epigenetic and gene expression analysis revealed that sex
has a considerable influence on the methylation pattern of the genes studied and, to a lesser
extent, so do APOE genotype and postnatal exposure to CPF. These results highlight the
importance of the sexual-dimorphic regulation of the hypothalamus circuits involved in
metabolic homeostasis. Increasing evidence indicates important differences between males
and females in the hypothalamic control of energy metabolism [55,68,69] and different
sensitivities to environmental factors [61]. Various studies in humans have also reported
an overall influence of sex on methylation status [70–72], supporting the importance of the
current results.
In the scientific literature, there is extensive evidence on how dietary interventions
can alter epigenetic regulation. However, there is less information about how existing
modifications can condition the response to an environmental challenge. We hypothesized
that the differences in methylation above discussed could condition the individual response
to an obesogenic environment such as the introduction of a high-fat diet. Certainly, the
introduction of a HFD over a long period of time would lead to metabolic changes, but the
eventual response depends on individual features [73]. In the present study, we found that
both male and female CPF-treated apoE4-TR mice showed significantly higher BW than
their respective controls at PND 28. This effect was not noticed in the apoE3-TR mice that
had been subjected to the same postnatal treatment. An APOE genotype specific effect of
CPF treatment was also observed by Peris-Sampedro et al. (2020) [74] at the exact same
period in apoE4-TR but not in C57BL/6 females. These observations suggest a greater
vulnerability of apoE4-TR mice to BW alterations at young ages.
During the dietary intervention, most of the groups presented a time- and diet- depen-
dent increase in BW. However, CPF-treated apoE4-TR males presented a different response
to the diet for the first three weeks, suggesting that subtle basal differences intrinsic to the
APOE4 genotype could be exacerbated by a dietary intervention. In a previous investiga-
tion, we found that a scheduled restricted presentation of a high-fat diet induced a higher
intake of palatable food in female mice postnatally exposed to CPF, being apoE4-TR mice
the most sensitive to the discontinuation of the diet, with a higher “wanting” response
with refeeding [74]. Therefore, the fact that we did not observe a similar pattern in the
current study suggests that a scheduled restricted presentation of a high-fat diet may have
subtle effects that cannot be observed with unrestricted access to the diet, which highlights
the importance of the administration protocol. The introduction of a HFD can increase
leptin levels in male and female rats [75], and also increases BW and insulin in mice [13].
In turn, Lassiter and Brimijoin (2008) [76] found increased BW in male but not female adult
rats exposed to CPF during gestation, while studies in rats developmentally exposed to a
different organophosphate pesticide, parathion, found that a HFD aggravates the effects of
the pesticide on metabolic parameters [77]. Therefore, we can infer that the synergic effect
of the APOE4 genotype and developmental exposure to CPF might predispose apoE4-TR
males to a different metabolic response to the introduction of an HFD.
Lassiter and Brimijoin (2008) [76] observed a loss of correlation between BW and
leptin levels in serum after CPF exposure, and put forward the leptin pathway as a poten-
tial mechanism underlying this loss. Interestingly, the leptin surge in rodents peaks on
PND 9—PND 10 [78]. It has been reported that modifications in this period may induce
long-term effects on leptin signaling [79]. In this sense, Attig et al. (2008) [80] found that
disrupting leptin during the first two postnatal weeks in female rats induced leptin resis-
tance during adulthood, and predisposed them to diet-induced obesity. Therefore, we can
hypothesize that the CPF-triggered disruption of leptin levels during the postnatal period
may contribute to the effects of treatment observed later in life. In parallel, Lepr mRNA has
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been observed to be higher in young apoE4-TR than in apoE3-TR mice [81]. As mentioned
above, the APOE4 genotype and CPF influence the gene expression levels of Lepr in the
hypothalamus, which negatively correlated to the methylation levels in the Lepr promoter.
Finally, this dysregulation in apoE4-TR mice can be also linked to the differences observed
in Npy methylation levels after treatment on males, which may be an overcompensation
caused by a CPF-triggered alteration in the leptin pathway.
5. Conclusions
To sum up, epigenetic modifications and gene expression are modulated by several fac-
tors, which lead to different long-term regulations. Sex plays an unequivocally important
role in the methylation pattern of genes involved in appetite regulation. Its influence may
underlie the sex-dependent differences in basal BW. In fact, males and females presented
a different BW progression pattern during the dietary challenge. Remarkably, the APOE
genotype was an important factor in the epigenetic regulation of Lepr and its contribution
to possible metabolic alterations deserves further investigations. With respect to the pro-
gression of BW, apoE4-TR males presented higher susceptibility to the cumulative effects
of both HFD and postnatal CPF treatment. Moreover, apoE4-TR male mice also showed
differences in the methylation of Npy after CPF exposure. In conclusion, developmental ex-
posure to CPF, together with individual differences involving sex and the APOE genotype,
may contribute to the global incidence of overweight and obesity.
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